Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Profiling human Src homology 2 (SH2) domain proteins and ligand discovery using a peptide-hybrid small molecule microarray.

Fu J, Na Z, Uttamchandani M, Yao SQ.

Chem Commun (Camb). 2013 Oct 25;49(83):9660-2. doi: 10.1039/c3cc45413d.

PMID:
24022784
2.

Antagonists of the Src homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70.

García-Echeverria C.

Curr Med Chem. 2001 Nov;8(13):1589-604. Review.

PMID:
11562287
3.

Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.

Hofmann G, Schweimer K, Kiessling A, Hofinger E, Bauer F, Hoffmann S, Rösch P, Campbell ID, Werner JM, Sticht H.

Biochemistry. 2005 Oct 4;44(39):13043-50.

PMID:
16185072
4.

Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.

Ahn SC, Oh WK, Kim BY, Kang DO, Kim MS, Heo GY, Ahn JS.

Planta Med. 2003 Jul;69(7):642-6.

PMID:
12898421
5.

Role of herpes simplex virus VP11/12 tyrosine-based motifs in binding and activation of the Src family kinase Lck and recruitment of p85, Grb2, and Shc.

Strunk U, Saffran HA, Wu FW, Smiley JR.

J Virol. 2013 Oct;87(20):11276-86. doi: 10.1128/JVI.01702-13. Epub 2013 Aug 14.

6.

Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker.

Yan Q, Barros T, Visperas PR, Deindl S, Kadlecek TA, Weiss A, Kuriyan J.

Mol Cell Biol. 2013 Jun;33(11):2188-201. doi: 10.1128/MCB.01637-12. Epub 2013 Mar 25.

7.

Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries.

Hart CP, Martin JE, Reed MA, Keval AA, Pustelnik MJ, Northrop JP, Patel DV, Grove JR.

Cell Signal. 1999 Jun;11(6):453-64.

PMID:
10400318
8.

Progress towards the development of SH2 domain inhibitors.

Kraskouskaya D, Duodu E, Arpin CC, Gunning PT.

Chem Soc Rev. 2013 Apr 21;42(8):3337-70. doi: 10.1039/c3cs35449k. Epub 2013 Feb 11. Review.

PMID:
23396540
9.

Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain.

Oligino L, Lung FD, Sastry L, Bigelow J, Cao T, Curran M, Burke TR Jr, Wang S, Krag D, Roller PP, King CR.

J Biol Chem. 1997 Nov 14;272(46):29046-52.

10.
12.

SH2-directed ligands of the Lck tyrosine kinase.

Lee TR, Lawrence DS.

J Med Chem. 2000 Mar 23;43(6):1173-9.

PMID:
10737750
13.
14.

Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.

Panchamoorthy G, Fukazawa T, Stolz L, Payne G, Reedquist K, Shoelson S, Songyang Z, Cantley L, Walsh C, Band H.

Mol Cell Biol. 1994 Sep;14(9):6372-85.

15.

Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.

Gram H, Schmitz R, Zuber JF, Baumann G.

Eur J Biochem. 1997 Jun 15;246(3):633-7.

16.

Involvement of Src-homology-2-domain-containing protein-tyrosine phosphatase 2 in T cell activation.

Tailor P, Jascur T, Williams S, von Willebrand M, Couture C, Mustelin T.

Eur J Biochem. 1996 May 1;237(3):736-42.

17.

Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.

Lung FD, Tsai JY.

Biopolymers. 2003;71(2):132-40. Review.

PMID:
12767115
18.

Growth factor receptor-bound protein 2 (Grb2) association with hemopoietic specific protein 1: linkage between Lck and Grb2.

Takemoto Y, Furuta M, Sato M, Findell PR, Ramble W, Hashimoto Y.

J Immunol. 1998 Jul 15;161(2):625-30.

19.

Regulation of the Lck SH2 domain by tyrosine phosphorylation.

Couture C, Songyang Z, Jascur T, Williams S, Tailor P, Cantley LC, Mustelin T.

J Biol Chem. 1996 Oct 4;271(40):24880-4.

20.

Structure of the regulatory domains of the Src-family tyrosine kinase Lck.

Eck MJ, Atwell SK, Shoelson SE, Harrison SC.

Nature. 1994 Apr 21;368(6473):764-9.

PMID:
7512222
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk